Evidence check: DNA Stoffwechseltest in the context of longevity

The question of a DNA metabolism test in the context of longevity requires critical evaluation. Based on the provided context, MyBody-X tests focus on metabolism and nutrition but are not specifically validated for longevity prediction. The evidence is largely marketing-driven: no direct longevity genes (e.g., FOXO3, SIRT1) are mentioned; instead, general metabolic markers (e.g., IL-6, CRP) and single SNPs (e.g., MC4R, TCF7L2) with small effect sizes are used. The link between these markers and lifespan is indirect and confounded by lifestyle factors. GWAS-derived associations are population-specific and do not allow causal individual predictions. A DNA test can offer hints about genetic predispositions but cannot reliably forecast longevity. For evidence-based longevity advice, clinical biomarkers (e.g., hs-CRP, HbA1c) and lifestyle assessment are far more relevant. Caveat: These tests are not approved for medical diagnosis; professional medical interpretation is recommended.